Global saRNA Synthesis Service Supply, Demand and Key Producers, 2026-2032
The global saRNA Synthesis Service market size is expected to reach $ 346 million by 2032, rising at a market growth of 19.3% CAGR during the forecast period (2026-2032).
saRNA Synthesis Service refers to the customized production of long RNA constructs containing an RNA replicase-coding region, a subgenomic promoter, and a target protein-coding sequence. Using plasmid DNA or linear DNA as the template, service providers perform replicon and sequence optimization, in vitro transcription, 5? capping, 3? poly(A) tail construction, nucleotide modification, purification, bioburden control, and quality testing. saRNA constructs are generally longer and structurally more complex than conventional mRNA, creating higher requirements for DNA template integrity, long-transcript yield, full-length RNA content, double-stranded RNA impurity control, and potency testing. Major upstream inputs include plasmid or linear DNA templates, natural and modified NTPs, T7 RNA polymerase, cap analogs or capping enzymes, poly(A) polymerase, DNase, buffers, chromatography resins, ultrafiltration membranes, and single-use consumables. Major downstream customers include vaccine companies, biotechnology companies, pharmaceutical companies, academic institutions, CROs, and CDMOs. The industry's overall gross profit margin is approximately 45%-62%.
The global saRNA synthesis service market remains in transition from research validation to clinical development and commercial manufacturing. It is less mature than the conventional mRNA service market, but saRNA projects generally involve higher technical barriers, greater customer switching costs, and higher clinical project values. Current orders are concentrated in infectious disease vaccines, cancer vaccines, immunotherapy, and protein expression platforms. Research-grade and preclinical projects account for most order volume, while GMP projects contribute a larger share of revenue because they require process development, analytical method establishment, validation, and release testing. Regulatory approvals and commercial production of saRNA products have further demonstrated the manufacturability and regulatory feasibility of the modality.
Competition is shifting from the basic ability to synthesize long RNA toward comprehensive control of full-length RNA content, capping efficiency, poly(A) tail consistency, double-stranded RNA impurities, residual DNA, endotoxin, and biological potency. saRNA constructs contain long replicase-coding regions and are more susceptible to premature termination, template-dependent by-products, RNA degradation, and incorrect folding. Service providers must optimize template structure, magnesium concentration, NTP ratios, transcription temperature, capping methods, and purification routes for different replicon backbones. High-resolution chromatography, tangential flow filtration, low-dsRNA processes, and cell-based potency assays are becoming important differentiating capabilities.
Market growth is primarily driven by demand for low-dose vaccines, sustained protein expression, new cancer immunotherapies, and increased outsourcing of RNA therapeutic development. After entering cells, saRNA can use its encoded replicase to generate additional RNA copies, potentially achieving stronger or longer-lasting protein expression from a lower initial dose. Small and medium-sized biotechnology companies frequently lack long-RNA process development capabilities, dedicated manufacturing facilities, and GMP quality systems. They are therefore more likely to outsource sequence design, template production, IVT optimization, purification, and quality testing. Providers capable of supporting continuous scale-up from research batches to clinical and commercial manufacturing are more likely to secure long-term programs.
Industry development remains constrained by limited long-RNA stability, difficult process scale-up, incomplete standardization of analytical requirements, and long clinical conversion cycles. Different replicon backbones, antigen sequences, and nucleotide modification strategies can produce substantially different transcription yields, immunogenicity profiles, and in vivo expression levels, making universal manufacturing processes difficult to apply. Intellectual property associated with critical enzymes, capping technologies, modified nucleotides, and delivery systems may also increase licensing costs and supply chain complexity. In addition, the dose-sparing advantage of saRNA may reduce the mass of RNA required during commercial manufacturing. Future market growth will therefore depend more on project numbers, process development intensity, and high-value GMP services than on RNA volume alone.
This report studies the global saRNA Synthesis Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for saRNA Synthesis Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of saRNA Synthesis Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global saRNA Synthesis Service total market, 2021-2032, (USD Million)
Global saRNA Synthesis Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: saRNA Synthesis Service total market, key domestic companies, and share, (USD Million)
Global saRNA Synthesis Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global saRNA Synthesis Service total market by Type, CAGR, 2021-2032, (USD Million)
Global saRNA Synthesis Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global saRNA Synthesis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Maravai LifeSciences, Danaher, GenScript, Catalent, Lonza, Thermo Fisher Scientific, Samsung Biologics, Recipharm, Wacker, Curia, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world saRNA Synthesis Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global saRNA Synthesis Service Market, By Region:
1. How big is the global saRNA Synthesis Service market?
2. What is the demand of the global saRNA Synthesis Service market?
3. What is the year over year growth of the global saRNA Synthesis Service market?
4. What is the total value of the global saRNA Synthesis Service market?
5. Who are the Major Players in the global saRNA Synthesis Service market?
6. What are the growth factors driving the market demand?
saRNA Synthesis Service refers to the customized production of long RNA constructs containing an RNA replicase-coding region, a subgenomic promoter, and a target protein-coding sequence. Using plasmid DNA or linear DNA as the template, service providers perform replicon and sequence optimization, in vitro transcription, 5? capping, 3? poly(A) tail construction, nucleotide modification, purification, bioburden control, and quality testing. saRNA constructs are generally longer and structurally more complex than conventional mRNA, creating higher requirements for DNA template integrity, long-transcript yield, full-length RNA content, double-stranded RNA impurity control, and potency testing. Major upstream inputs include plasmid or linear DNA templates, natural and modified NTPs, T7 RNA polymerase, cap analogs or capping enzymes, poly(A) polymerase, DNase, buffers, chromatography resins, ultrafiltration membranes, and single-use consumables. Major downstream customers include vaccine companies, biotechnology companies, pharmaceutical companies, academic institutions, CROs, and CDMOs. The industry's overall gross profit margin is approximately 45%-62%.
The global saRNA synthesis service market remains in transition from research validation to clinical development and commercial manufacturing. It is less mature than the conventional mRNA service market, but saRNA projects generally involve higher technical barriers, greater customer switching costs, and higher clinical project values. Current orders are concentrated in infectious disease vaccines, cancer vaccines, immunotherapy, and protein expression platforms. Research-grade and preclinical projects account for most order volume, while GMP projects contribute a larger share of revenue because they require process development, analytical method establishment, validation, and release testing. Regulatory approvals and commercial production of saRNA products have further demonstrated the manufacturability and regulatory feasibility of the modality.
Competition is shifting from the basic ability to synthesize long RNA toward comprehensive control of full-length RNA content, capping efficiency, poly(A) tail consistency, double-stranded RNA impurities, residual DNA, endotoxin, and biological potency. saRNA constructs contain long replicase-coding regions and are more susceptible to premature termination, template-dependent by-products, RNA degradation, and incorrect folding. Service providers must optimize template structure, magnesium concentration, NTP ratios, transcription temperature, capping methods, and purification routes for different replicon backbones. High-resolution chromatography, tangential flow filtration, low-dsRNA processes, and cell-based potency assays are becoming important differentiating capabilities.
Market growth is primarily driven by demand for low-dose vaccines, sustained protein expression, new cancer immunotherapies, and increased outsourcing of RNA therapeutic development. After entering cells, saRNA can use its encoded replicase to generate additional RNA copies, potentially achieving stronger or longer-lasting protein expression from a lower initial dose. Small and medium-sized biotechnology companies frequently lack long-RNA process development capabilities, dedicated manufacturing facilities, and GMP quality systems. They are therefore more likely to outsource sequence design, template production, IVT optimization, purification, and quality testing. Providers capable of supporting continuous scale-up from research batches to clinical and commercial manufacturing are more likely to secure long-term programs.
Industry development remains constrained by limited long-RNA stability, difficult process scale-up, incomplete standardization of analytical requirements, and long clinical conversion cycles. Different replicon backbones, antigen sequences, and nucleotide modification strategies can produce substantially different transcription yields, immunogenicity profiles, and in vivo expression levels, making universal manufacturing processes difficult to apply. Intellectual property associated with critical enzymes, capping technologies, modified nucleotides, and delivery systems may also increase licensing costs and supply chain complexity. In addition, the dose-sparing advantage of saRNA may reduce the mass of RNA required during commercial manufacturing. Future market growth will therefore depend more on project numbers, process development intensity, and high-value GMP services than on RNA volume alone.
This report studies the global saRNA Synthesis Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for saRNA Synthesis Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of saRNA Synthesis Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global saRNA Synthesis Service total market, 2021-2032, (USD Million)
Global saRNA Synthesis Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: saRNA Synthesis Service total market, key domestic companies, and share, (USD Million)
Global saRNA Synthesis Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global saRNA Synthesis Service total market by Type, CAGR, 2021-2032, (USD Million)
Global saRNA Synthesis Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global saRNA Synthesis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Maravai LifeSciences, Danaher, GenScript, Catalent, Lonza, Thermo Fisher Scientific, Samsung Biologics, Recipharm, Wacker, Curia, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world saRNA Synthesis Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global saRNA Synthesis Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Research Grade
- Preclinical Grade
- GMP Grade
- Other
- Micro Scale (?1 mg)
- Small Scale (>1?100 mg)
- Pilot Scale (>100 mg?10 g)
- Manufacturing Scale (>10 g)
- Unmodified saRNA
- Modified saRNA
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Other
- Maravai LifeSciences
- Danaher
- GenScript
- Catalent
- Lonza
- Thermo Fisher Scientific
- Samsung Biologics
- Recipharm
- Wacker
- Curia
- Biomay
- ARCALIS
- VectorBuilder
- Creative Biogene
1. How big is the global saRNA Synthesis Service market?
2. What is the demand of the global saRNA Synthesis Service market?
3. What is the year over year growth of the global saRNA Synthesis Service market?
4. What is the total value of the global saRNA Synthesis Service market?
5. Who are the Major Players in the global saRNA Synthesis Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 saRNA Synthesis Service Introduction
1.2 World saRNA Synthesis Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World saRNA Synthesis Service Total Market by Region (by Headquarter Location)
1.3.1 World saRNA Synthesis Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company saRNA Synthesis Service Revenue (2021-2032)
1.3.3 China Based Company saRNA Synthesis Service Revenue (2021-2032)
1.3.4 Europe Based Company saRNA Synthesis Service Revenue (2021-2032)
1.3.5 Japan Based Company saRNA Synthesis Service Revenue (2021-2032)
1.3.6 South Korea Based Company saRNA Synthesis Service Revenue (2021-2032)
1.3.7 ASEAN Based Company saRNA Synthesis Service Revenue (2021-2032)
1.3.8 India Based Company saRNA Synthesis Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 saRNA Synthesis Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World saRNA Synthesis Service Consumption Value (2021-2032)
2.2 World saRNA Synthesis Service Consumption Value by Region
2.2.1 World saRNA Synthesis Service Consumption Value by Region (2021-2026)
2.2.2 World saRNA Synthesis Service Consumption Value Forecast by Region (2027-2032)
2.3 United States saRNA Synthesis Service Consumption Value (2021-2032)
2.4 China saRNA Synthesis Service Consumption Value (2021-2032)
2.5 Europe saRNA Synthesis Service Consumption Value (2021-2032)
2.6 Japan saRNA Synthesis Service Consumption Value (2021-2032)
2.7 South Korea saRNA Synthesis Service Consumption Value (2021-2032)
2.8 ASEAN saRNA Synthesis Service Consumption Value (2021-2032)
2.9 India saRNA Synthesis Service Consumption Value (2021-2032)
3 WORLD SARNA SYNTHESIS SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World saRNA Synthesis Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global saRNA Synthesis Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for saRNA Synthesis Service in 2025
3.2.3 Global Concentration Ratios (CR8) for saRNA Synthesis Service in 2025
3.3 saRNA Synthesis Service Company Evaluation Quadrant
3.4 saRNA Synthesis Service Market: Overall Company Footprint Analysis
3.4.1 saRNA Synthesis Service Market: Region Footprint
3.4.2 saRNA Synthesis Service Market: Company Product Type Footprint
3.4.3 saRNA Synthesis Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: saRNA Synthesis Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: saRNA Synthesis Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: saRNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: saRNA Synthesis Service Consumption Value Comparison
4.2.1 United States VS China: saRNA Synthesis Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: saRNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based saRNA Synthesis Service Companies and Market Share, 2021-2026
4.3.1 United States Based saRNA Synthesis Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies saRNA Synthesis Service Revenue, (2021-2026)
4.4 China Based Companies saRNA Synthesis Service Revenue and Market Share, 2021-2026
4.4.1 China Based saRNA Synthesis Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies saRNA Synthesis Service Revenue, (2021-2026)
4.5 Rest of World Based saRNA Synthesis Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based saRNA Synthesis Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies saRNA Synthesis Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World saRNA Synthesis Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Research Grade
5.2.2 Preclinical Grade
5.2.3 GMP Grade
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World saRNA Synthesis Service Market Size by Type (2021-2026)
5.3.2 World saRNA Synthesis Service Market Size by Type (2027-2032)
5.3.3 World saRNA Synthesis Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY BATCH SCALE
6.1 World saRNA Synthesis Service Market Size Overview by Batch Scale: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Batch Scale
6.2.1 Micro Scale (?1 mg)
6.2.2 Small Scale (>1?100 mg)
6.2.3 Pilot Scale (>100 mg?10 g)
6.2.4 Manufacturing Scale (>10 g)
6.3 Market Segment by Batch Scale
6.3.1 World saRNA Synthesis Service Market Size by Batch Scale (2021-2026)
6.3.2 World saRNA Synthesis Service Market Size by Batch Scale (2027-2032)
6.3.3 World saRNA Synthesis Service Market Size Market Share by Batch Scale (2027-2032)
7 MARKET ANALYSIS BY NUCLEOTIDE COMPOSITION
7.1 World saRNA Synthesis Service Market Size Overview by Nucleotide Composition: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Nucleotide Composition
7.2.1 Unmodified saRNA
7.2.2 Modified saRNA
7.3 Market Segment by Nucleotide Composition
7.3.1 World saRNA Synthesis Service Market Size by Nucleotide Composition (2021-2026)
7.3.2 World saRNA Synthesis Service Market Size by Nucleotide Composition (2027-2032)
7.3.3 World saRNA Synthesis Service Market Size Market Share by Nucleotide Composition (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World saRNA Synthesis Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical and Biotechnology Companies
8.2.2 Academic and Research Institutes
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World saRNA Synthesis Service Market Size by Application (2021-2026)
8.3.2 World saRNA Synthesis Service Market Size by Application (2027-2032)
8.3.3 World saRNA Synthesis Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Maravai LifeSciences
9.1.1 Maravai LifeSciences Details
9.1.2 Maravai LifeSciences Major Business
9.1.3 Maravai LifeSciences saRNA Synthesis Service Product and Services
9.1.4 Maravai LifeSciences saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Maravai LifeSciences Recent Developments/Updates
9.1.6 Maravai LifeSciences Competitive Strengths & Weaknesses
9.2 Danaher
9.2.1 Danaher Details
9.2.2 Danaher Major Business
9.2.3 Danaher saRNA Synthesis Service Product and Services
9.2.4 Danaher saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Danaher Recent Developments/Updates
9.2.6 Danaher Competitive Strengths & Weaknesses
9.3 GenScript
9.3.1 GenScript Details
9.3.2 GenScript Major Business
9.3.3 GenScript saRNA Synthesis Service Product and Services
9.3.4 GenScript saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 GenScript Recent Developments/Updates
9.3.6 GenScript Competitive Strengths & Weaknesses
9.4 Catalent
9.4.1 Catalent Details
9.4.2 Catalent Major Business
9.4.3 Catalent saRNA Synthesis Service Product and Services
9.4.4 Catalent saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Catalent Recent Developments/Updates
9.4.6 Catalent Competitive Strengths & Weaknesses
9.5 Lonza
9.5.1 Lonza Details
9.5.2 Lonza Major Business
9.5.3 Lonza saRNA Synthesis Service Product and Services
9.5.4 Lonza saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Lonza Recent Developments/Updates
9.5.6 Lonza Competitive Strengths & Weaknesses
9.6 Thermo Fisher Scientific
9.6.1 Thermo Fisher Scientific Details
9.6.2 Thermo Fisher Scientific Major Business
9.6.3 Thermo Fisher Scientific saRNA Synthesis Service Product and Services
9.6.4 Thermo Fisher Scientific saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Thermo Fisher Scientific Recent Developments/Updates
9.6.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.7 Samsung Biologics
9.7.1 Samsung Biologics Details
9.7.2 Samsung Biologics Major Business
9.7.3 Samsung Biologics saRNA Synthesis Service Product and Services
9.7.4 Samsung Biologics saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Samsung Biologics Recent Developments/Updates
9.7.6 Samsung Biologics Competitive Strengths & Weaknesses
9.8 Recipharm
9.8.1 Recipharm Details
9.8.2 Recipharm Major Business
9.8.3 Recipharm saRNA Synthesis Service Product and Services
9.8.4 Recipharm saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Recipharm Recent Developments/Updates
9.8.6 Recipharm Competitive Strengths & Weaknesses
9.9 Wacker
9.9.1 Wacker Details
9.9.2 Wacker Major Business
9.9.3 Wacker saRNA Synthesis Service Product and Services
9.9.4 Wacker saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Wacker Recent Developments/Updates
9.9.6 Wacker Competitive Strengths & Weaknesses
9.10 Curia
9.10.1 Curia Details
9.10.2 Curia Major Business
9.10.3 Curia saRNA Synthesis Service Product and Services
9.10.4 Curia saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Curia Recent Developments/Updates
9.10.6 Curia Competitive Strengths & Weaknesses
9.11 Biomay
9.11.1 Biomay Details
9.11.2 Biomay Major Business
9.11.3 Biomay saRNA Synthesis Service Product and Services
9.11.4 Biomay saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Biomay Recent Developments/Updates
9.11.6 Biomay Competitive Strengths & Weaknesses
9.12 ARCALIS
9.12.1 ARCALIS Details
9.12.2 ARCALIS Major Business
9.12.3 ARCALIS saRNA Synthesis Service Product and Services
9.12.4 ARCALIS saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 ARCALIS Recent Developments/Updates
9.12.6 ARCALIS Competitive Strengths & Weaknesses
9.13 VectorBuilder
9.13.1 VectorBuilder Details
9.13.2 VectorBuilder Major Business
9.13.3 VectorBuilder saRNA Synthesis Service Product and Services
9.13.4 VectorBuilder saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 VectorBuilder Recent Developments/Updates
9.13.6 VectorBuilder Competitive Strengths & Weaknesses
9.14 Creative Biogene
9.14.1 Creative Biogene Details
9.14.2 Creative Biogene Major Business
9.14.3 Creative Biogene saRNA Synthesis Service Product and Services
9.14.4 Creative Biogene saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Creative Biogene Recent Developments/Updates
9.14.6 Creative Biogene Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 saRNA Synthesis Service Industry Chain
10.2 saRNA Synthesis Service Upstream Analysis
10.3 saRNA Synthesis Service Midstream Analysis
10.4 saRNA Synthesis Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 saRNA Synthesis Service Introduction
1.2 World saRNA Synthesis Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World saRNA Synthesis Service Total Market by Region (by Headquarter Location)
1.3.1 World saRNA Synthesis Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company saRNA Synthesis Service Revenue (2021-2032)
1.3.3 China Based Company saRNA Synthesis Service Revenue (2021-2032)
1.3.4 Europe Based Company saRNA Synthesis Service Revenue (2021-2032)
1.3.5 Japan Based Company saRNA Synthesis Service Revenue (2021-2032)
1.3.6 South Korea Based Company saRNA Synthesis Service Revenue (2021-2032)
1.3.7 ASEAN Based Company saRNA Synthesis Service Revenue (2021-2032)
1.3.8 India Based Company saRNA Synthesis Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 saRNA Synthesis Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World saRNA Synthesis Service Consumption Value (2021-2032)
2.2 World saRNA Synthesis Service Consumption Value by Region
2.2.1 World saRNA Synthesis Service Consumption Value by Region (2021-2026)
2.2.2 World saRNA Synthesis Service Consumption Value Forecast by Region (2027-2032)
2.3 United States saRNA Synthesis Service Consumption Value (2021-2032)
2.4 China saRNA Synthesis Service Consumption Value (2021-2032)
2.5 Europe saRNA Synthesis Service Consumption Value (2021-2032)
2.6 Japan saRNA Synthesis Service Consumption Value (2021-2032)
2.7 South Korea saRNA Synthesis Service Consumption Value (2021-2032)
2.8 ASEAN saRNA Synthesis Service Consumption Value (2021-2032)
2.9 India saRNA Synthesis Service Consumption Value (2021-2032)
3 WORLD SARNA SYNTHESIS SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World saRNA Synthesis Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global saRNA Synthesis Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for saRNA Synthesis Service in 2025
3.2.3 Global Concentration Ratios (CR8) for saRNA Synthesis Service in 2025
3.3 saRNA Synthesis Service Company Evaluation Quadrant
3.4 saRNA Synthesis Service Market: Overall Company Footprint Analysis
3.4.1 saRNA Synthesis Service Market: Region Footprint
3.4.2 saRNA Synthesis Service Market: Company Product Type Footprint
3.4.3 saRNA Synthesis Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: saRNA Synthesis Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: saRNA Synthesis Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: saRNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: saRNA Synthesis Service Consumption Value Comparison
4.2.1 United States VS China: saRNA Synthesis Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: saRNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based saRNA Synthesis Service Companies and Market Share, 2021-2026
4.3.1 United States Based saRNA Synthesis Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies saRNA Synthesis Service Revenue, (2021-2026)
4.4 China Based Companies saRNA Synthesis Service Revenue and Market Share, 2021-2026
4.4.1 China Based saRNA Synthesis Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies saRNA Synthesis Service Revenue, (2021-2026)
4.5 Rest of World Based saRNA Synthesis Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based saRNA Synthesis Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies saRNA Synthesis Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World saRNA Synthesis Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Research Grade
5.2.2 Preclinical Grade
5.2.3 GMP Grade
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World saRNA Synthesis Service Market Size by Type (2021-2026)
5.3.2 World saRNA Synthesis Service Market Size by Type (2027-2032)
5.3.3 World saRNA Synthesis Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY BATCH SCALE
6.1 World saRNA Synthesis Service Market Size Overview by Batch Scale: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Batch Scale
6.2.1 Micro Scale (?1 mg)
6.2.2 Small Scale (>1?100 mg)
6.2.3 Pilot Scale (>100 mg?10 g)
6.2.4 Manufacturing Scale (>10 g)
6.3 Market Segment by Batch Scale
6.3.1 World saRNA Synthesis Service Market Size by Batch Scale (2021-2026)
6.3.2 World saRNA Synthesis Service Market Size by Batch Scale (2027-2032)
6.3.3 World saRNA Synthesis Service Market Size Market Share by Batch Scale (2027-2032)
7 MARKET ANALYSIS BY NUCLEOTIDE COMPOSITION
7.1 World saRNA Synthesis Service Market Size Overview by Nucleotide Composition: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Nucleotide Composition
7.2.1 Unmodified saRNA
7.2.2 Modified saRNA
7.3 Market Segment by Nucleotide Composition
7.3.1 World saRNA Synthesis Service Market Size by Nucleotide Composition (2021-2026)
7.3.2 World saRNA Synthesis Service Market Size by Nucleotide Composition (2027-2032)
7.3.3 World saRNA Synthesis Service Market Size Market Share by Nucleotide Composition (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World saRNA Synthesis Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical and Biotechnology Companies
8.2.2 Academic and Research Institutes
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World saRNA Synthesis Service Market Size by Application (2021-2026)
8.3.2 World saRNA Synthesis Service Market Size by Application (2027-2032)
8.3.3 World saRNA Synthesis Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Maravai LifeSciences
9.1.1 Maravai LifeSciences Details
9.1.2 Maravai LifeSciences Major Business
9.1.3 Maravai LifeSciences saRNA Synthesis Service Product and Services
9.1.4 Maravai LifeSciences saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Maravai LifeSciences Recent Developments/Updates
9.1.6 Maravai LifeSciences Competitive Strengths & Weaknesses
9.2 Danaher
9.2.1 Danaher Details
9.2.2 Danaher Major Business
9.2.3 Danaher saRNA Synthesis Service Product and Services
9.2.4 Danaher saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Danaher Recent Developments/Updates
9.2.6 Danaher Competitive Strengths & Weaknesses
9.3 GenScript
9.3.1 GenScript Details
9.3.2 GenScript Major Business
9.3.3 GenScript saRNA Synthesis Service Product and Services
9.3.4 GenScript saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 GenScript Recent Developments/Updates
9.3.6 GenScript Competitive Strengths & Weaknesses
9.4 Catalent
9.4.1 Catalent Details
9.4.2 Catalent Major Business
9.4.3 Catalent saRNA Synthesis Service Product and Services
9.4.4 Catalent saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Catalent Recent Developments/Updates
9.4.6 Catalent Competitive Strengths & Weaknesses
9.5 Lonza
9.5.1 Lonza Details
9.5.2 Lonza Major Business
9.5.3 Lonza saRNA Synthesis Service Product and Services
9.5.4 Lonza saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Lonza Recent Developments/Updates
9.5.6 Lonza Competitive Strengths & Weaknesses
9.6 Thermo Fisher Scientific
9.6.1 Thermo Fisher Scientific Details
9.6.2 Thermo Fisher Scientific Major Business
9.6.3 Thermo Fisher Scientific saRNA Synthesis Service Product and Services
9.6.4 Thermo Fisher Scientific saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Thermo Fisher Scientific Recent Developments/Updates
9.6.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.7 Samsung Biologics
9.7.1 Samsung Biologics Details
9.7.2 Samsung Biologics Major Business
9.7.3 Samsung Biologics saRNA Synthesis Service Product and Services
9.7.4 Samsung Biologics saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Samsung Biologics Recent Developments/Updates
9.7.6 Samsung Biologics Competitive Strengths & Weaknesses
9.8 Recipharm
9.8.1 Recipharm Details
9.8.2 Recipharm Major Business
9.8.3 Recipharm saRNA Synthesis Service Product and Services
9.8.4 Recipharm saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Recipharm Recent Developments/Updates
9.8.6 Recipharm Competitive Strengths & Weaknesses
9.9 Wacker
9.9.1 Wacker Details
9.9.2 Wacker Major Business
9.9.3 Wacker saRNA Synthesis Service Product and Services
9.9.4 Wacker saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Wacker Recent Developments/Updates
9.9.6 Wacker Competitive Strengths & Weaknesses
9.10 Curia
9.10.1 Curia Details
9.10.2 Curia Major Business
9.10.3 Curia saRNA Synthesis Service Product and Services
9.10.4 Curia saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Curia Recent Developments/Updates
9.10.6 Curia Competitive Strengths & Weaknesses
9.11 Biomay
9.11.1 Biomay Details
9.11.2 Biomay Major Business
9.11.3 Biomay saRNA Synthesis Service Product and Services
9.11.4 Biomay saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Biomay Recent Developments/Updates
9.11.6 Biomay Competitive Strengths & Weaknesses
9.12 ARCALIS
9.12.1 ARCALIS Details
9.12.2 ARCALIS Major Business
9.12.3 ARCALIS saRNA Synthesis Service Product and Services
9.12.4 ARCALIS saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 ARCALIS Recent Developments/Updates
9.12.6 ARCALIS Competitive Strengths & Weaknesses
9.13 VectorBuilder
9.13.1 VectorBuilder Details
9.13.2 VectorBuilder Major Business
9.13.3 VectorBuilder saRNA Synthesis Service Product and Services
9.13.4 VectorBuilder saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 VectorBuilder Recent Developments/Updates
9.13.6 VectorBuilder Competitive Strengths & Weaknesses
9.14 Creative Biogene
9.14.1 Creative Biogene Details
9.14.2 Creative Biogene Major Business
9.14.3 Creative Biogene saRNA Synthesis Service Product and Services
9.14.4 Creative Biogene saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Creative Biogene Recent Developments/Updates
9.14.6 Creative Biogene Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 saRNA Synthesis Service Industry Chain
10.2 saRNA Synthesis Service Upstream Analysis
10.3 saRNA Synthesis Service Midstream Analysis
10.4 saRNA Synthesis Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World saRNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World saRNA Synthesis Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World saRNA Synthesis Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World saRNA Synthesis Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World saRNA Synthesis Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World saRNA Synthesis Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World saRNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World saRNA Synthesis Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World saRNA Synthesis Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key saRNA Synthesis Service Players in 2025
Table 12. World saRNA Synthesis Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global saRNA Synthesis Service Company Evaluation Quadrant
Table 14. Head Office of Key saRNA Synthesis Service Players
Table 15. saRNA Synthesis Service Market: Company Product Type Footprint
Table 16. saRNA Synthesis Service Market: Company Product Application Footprint
Table 17. saRNA Synthesis Service Mergers & Acquisitions Activity
Table 18. United States VS China saRNA Synthesis Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China saRNA Synthesis Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based saRNA Synthesis Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies saRNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies saRNA Synthesis Service Revenue Market Share (2021-2026)
Table 23. China Based saRNA Synthesis Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies saRNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies saRNA Synthesis Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based saRNA Synthesis Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies saRNA Synthesis Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies saRNA Synthesis Service Revenue Market Share (2021-2026)
Table 29. World saRNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World saRNA Synthesis Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World saRNA Synthesis Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World saRNA Synthesis Service Market Size by Batch Scale, (USD Million), 2021 & 2025 & 2032
Table 33. World saRNA Synthesis Service Market Size Value by Batch Scale (2021-2026) & (USD Million)
Table 34. World saRNA Synthesis Service Market Size by Batch Scale (2027-2032) & (USD Million)
Table 35. World saRNA Synthesis Service Market Size by Nucleotide Composition, (USD Million), 2021 & 2025 & 2032
Table 36. World saRNA Synthesis Service Market Size Value by Nucleotide Composition (2021-2026) & (USD Million)
Table 37. World saRNA Synthesis Service Market Size by Nucleotide Composition (2027-2032) & (USD Million)
Table 38. World saRNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World saRNA Synthesis Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World saRNA Synthesis Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Maravai LifeSciences Basic Information, Manufacturing Base and Competitors
Table 42. Maravai LifeSciences Major Business
Table 43. Maravai LifeSciences saRNA Synthesis Service Product and Services
Table 44. Maravai LifeSciences saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Maravai LifeSciences Recent Developments/Updates
Table 46. Maravai LifeSciences Competitive Strengths & Weaknesses
Table 47. Danaher Basic Information, Manufacturing Base and Competitors
Table 48. Danaher Major Business
Table 49. Danaher saRNA Synthesis Service Product and Services
Table 50. Danaher saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Danaher Recent Developments/Updates
Table 52. Danaher Competitive Strengths & Weaknesses
Table 53. GenScript Basic Information, Manufacturing Base and Competitors
Table 54. GenScript Major Business
Table 55. GenScript saRNA Synthesis Service Product and Services
Table 56. GenScript saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. GenScript Recent Developments/Updates
Table 58. GenScript Competitive Strengths & Weaknesses
Table 59. Catalent Basic Information, Manufacturing Base and Competitors
Table 60. Catalent Major Business
Table 61. Catalent saRNA Synthesis Service Product and Services
Table 62. Catalent saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Catalent Recent Developments/Updates
Table 64. Catalent Competitive Strengths & Weaknesses
Table 65. Lonza Basic Information, Manufacturing Base and Competitors
Table 66. Lonza Major Business
Table 67. Lonza saRNA Synthesis Service Product and Services
Table 68. Lonza saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Lonza Recent Developments/Updates
Table 70. Lonza Competitive Strengths & Weaknesses
Table 71. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 72. Thermo Fisher Scientific Major Business
Table 73. Thermo Fisher Scientific saRNA Synthesis Service Product and Services
Table 74. Thermo Fisher Scientific saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Thermo Fisher Scientific Recent Developments/Updates
Table 76. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 77. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 78. Samsung Biologics Major Business
Table 79. Samsung Biologics saRNA Synthesis Service Product and Services
Table 80. Samsung Biologics saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Samsung Biologics Recent Developments/Updates
Table 82. Samsung Biologics Competitive Strengths & Weaknesses
Table 83. Recipharm Basic Information, Manufacturing Base and Competitors
Table 84. Recipharm Major Business
Table 85. Recipharm saRNA Synthesis Service Product and Services
Table 86. Recipharm saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Recipharm Recent Developments/Updates
Table 88. Recipharm Competitive Strengths & Weaknesses
Table 89. Wacker Basic Information, Manufacturing Base and Competitors
Table 90. Wacker Major Business
Table 91. Wacker saRNA Synthesis Service Product and Services
Table 92. Wacker saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Wacker Recent Developments/Updates
Table 94. Wacker Competitive Strengths & Weaknesses
Table 95. Curia Basic Information, Manufacturing Base and Competitors
Table 96. Curia Major Business
Table 97. Curia saRNA Synthesis Service Product and Services
Table 98. Curia saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Curia Recent Developments/Updates
Table 100. Curia Competitive Strengths & Weaknesses
Table 101. Biomay Basic Information, Manufacturing Base and Competitors
Table 102. Biomay Major Business
Table 103. Biomay saRNA Synthesis Service Product and Services
Table 104. Biomay saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Biomay Recent Developments/Updates
Table 106. Biomay Competitive Strengths & Weaknesses
Table 107. ARCALIS Basic Information, Manufacturing Base and Competitors
Table 108. ARCALIS Major Business
Table 109. ARCALIS saRNA Synthesis Service Product and Services
Table 110. ARCALIS saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. ARCALIS Recent Developments/Updates
Table 112. ARCALIS Competitive Strengths & Weaknesses
Table 113. VectorBuilder Basic Information, Manufacturing Base and Competitors
Table 114. VectorBuilder Major Business
Table 115. VectorBuilder saRNA Synthesis Service Product and Services
Table 116. VectorBuilder saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. VectorBuilder Recent Developments/Updates
Table 118. VectorBuilder Competitive Strengths & Weaknesses
Table 119. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 120. Creative Biogene Major Business
Table 121. Creative Biogene saRNA Synthesis Service Product and Services
Table 122. Creative Biogene saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Creative Biogene Recent Developments/Updates
Table 124. Creative Biogene Competitive Strengths & Weaknesses
Table 125. Global Key Players of saRNA Synthesis Service Upstream (Raw Materials)
Table 126. Global saRNA Synthesis Service Typical Customers
Table 1. World saRNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World saRNA Synthesis Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World saRNA Synthesis Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World saRNA Synthesis Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World saRNA Synthesis Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World saRNA Synthesis Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World saRNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World saRNA Synthesis Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World saRNA Synthesis Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key saRNA Synthesis Service Players in 2025
Table 12. World saRNA Synthesis Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global saRNA Synthesis Service Company Evaluation Quadrant
Table 14. Head Office of Key saRNA Synthesis Service Players
Table 15. saRNA Synthesis Service Market: Company Product Type Footprint
Table 16. saRNA Synthesis Service Market: Company Product Application Footprint
Table 17. saRNA Synthesis Service Mergers & Acquisitions Activity
Table 18. United States VS China saRNA Synthesis Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China saRNA Synthesis Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based saRNA Synthesis Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies saRNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies saRNA Synthesis Service Revenue Market Share (2021-2026)
Table 23. China Based saRNA Synthesis Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies saRNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies saRNA Synthesis Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based saRNA Synthesis Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies saRNA Synthesis Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies saRNA Synthesis Service Revenue Market Share (2021-2026)
Table 29. World saRNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World saRNA Synthesis Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World saRNA Synthesis Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World saRNA Synthesis Service Market Size by Batch Scale, (USD Million), 2021 & 2025 & 2032
Table 33. World saRNA Synthesis Service Market Size Value by Batch Scale (2021-2026) & (USD Million)
Table 34. World saRNA Synthesis Service Market Size by Batch Scale (2027-2032) & (USD Million)
Table 35. World saRNA Synthesis Service Market Size by Nucleotide Composition, (USD Million), 2021 & 2025 & 2032
Table 36. World saRNA Synthesis Service Market Size Value by Nucleotide Composition (2021-2026) & (USD Million)
Table 37. World saRNA Synthesis Service Market Size by Nucleotide Composition (2027-2032) & (USD Million)
Table 38. World saRNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World saRNA Synthesis Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World saRNA Synthesis Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Maravai LifeSciences Basic Information, Manufacturing Base and Competitors
Table 42. Maravai LifeSciences Major Business
Table 43. Maravai LifeSciences saRNA Synthesis Service Product and Services
Table 44. Maravai LifeSciences saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Maravai LifeSciences Recent Developments/Updates
Table 46. Maravai LifeSciences Competitive Strengths & Weaknesses
Table 47. Danaher Basic Information, Manufacturing Base and Competitors
Table 48. Danaher Major Business
Table 49. Danaher saRNA Synthesis Service Product and Services
Table 50. Danaher saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Danaher Recent Developments/Updates
Table 52. Danaher Competitive Strengths & Weaknesses
Table 53. GenScript Basic Information, Manufacturing Base and Competitors
Table 54. GenScript Major Business
Table 55. GenScript saRNA Synthesis Service Product and Services
Table 56. GenScript saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. GenScript Recent Developments/Updates
Table 58. GenScript Competitive Strengths & Weaknesses
Table 59. Catalent Basic Information, Manufacturing Base and Competitors
Table 60. Catalent Major Business
Table 61. Catalent saRNA Synthesis Service Product and Services
Table 62. Catalent saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Catalent Recent Developments/Updates
Table 64. Catalent Competitive Strengths & Weaknesses
Table 65. Lonza Basic Information, Manufacturing Base and Competitors
Table 66. Lonza Major Business
Table 67. Lonza saRNA Synthesis Service Product and Services
Table 68. Lonza saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Lonza Recent Developments/Updates
Table 70. Lonza Competitive Strengths & Weaknesses
Table 71. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 72. Thermo Fisher Scientific Major Business
Table 73. Thermo Fisher Scientific saRNA Synthesis Service Product and Services
Table 74. Thermo Fisher Scientific saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Thermo Fisher Scientific Recent Developments/Updates
Table 76. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 77. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 78. Samsung Biologics Major Business
Table 79. Samsung Biologics saRNA Synthesis Service Product and Services
Table 80. Samsung Biologics saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Samsung Biologics Recent Developments/Updates
Table 82. Samsung Biologics Competitive Strengths & Weaknesses
Table 83. Recipharm Basic Information, Manufacturing Base and Competitors
Table 84. Recipharm Major Business
Table 85. Recipharm saRNA Synthesis Service Product and Services
Table 86. Recipharm saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Recipharm Recent Developments/Updates
Table 88. Recipharm Competitive Strengths & Weaknesses
Table 89. Wacker Basic Information, Manufacturing Base and Competitors
Table 90. Wacker Major Business
Table 91. Wacker saRNA Synthesis Service Product and Services
Table 92. Wacker saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Wacker Recent Developments/Updates
Table 94. Wacker Competitive Strengths & Weaknesses
Table 95. Curia Basic Information, Manufacturing Base and Competitors
Table 96. Curia Major Business
Table 97. Curia saRNA Synthesis Service Product and Services
Table 98. Curia saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Curia Recent Developments/Updates
Table 100. Curia Competitive Strengths & Weaknesses
Table 101. Biomay Basic Information, Manufacturing Base and Competitors
Table 102. Biomay Major Business
Table 103. Biomay saRNA Synthesis Service Product and Services
Table 104. Biomay saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Biomay Recent Developments/Updates
Table 106. Biomay Competitive Strengths & Weaknesses
Table 107. ARCALIS Basic Information, Manufacturing Base and Competitors
Table 108. ARCALIS Major Business
Table 109. ARCALIS saRNA Synthesis Service Product and Services
Table 110. ARCALIS saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. ARCALIS Recent Developments/Updates
Table 112. ARCALIS Competitive Strengths & Weaknesses
Table 113. VectorBuilder Basic Information, Manufacturing Base and Competitors
Table 114. VectorBuilder Major Business
Table 115. VectorBuilder saRNA Synthesis Service Product and Services
Table 116. VectorBuilder saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. VectorBuilder Recent Developments/Updates
Table 118. VectorBuilder Competitive Strengths & Weaknesses
Table 119. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 120. Creative Biogene Major Business
Table 121. Creative Biogene saRNA Synthesis Service Product and Services
Table 122. Creative Biogene saRNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Creative Biogene Recent Developments/Updates
Table 124. Creative Biogene Competitive Strengths & Weaknesses
Table 125. Global Key Players of saRNA Synthesis Service Upstream (Raw Materials)
Table 126. Global saRNA Synthesis Service Typical Customers
LIST OF FIGURES
Figure 1. saRNA Synthesis Service Picture
Figure 2. World saRNA Synthesis Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World saRNA Synthesis Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World saRNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World saRNA Synthesis Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company saRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company saRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company saRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company saRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company saRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company saRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company saRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 13. saRNA Synthesis Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World saRNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of saRNA Synthesis Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for saRNA Synthesis Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for saRNA Synthesis Service Markets in 2025
Figure 27. United States VS China: saRNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: saRNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World saRNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World saRNA Synthesis Service Market Size Market Share by Type in 2025
Figure 31. Research Grade
Figure 32. Preclinical Grade
Figure 33. GMP Grade
Figure 34. Other
Figure 35. World saRNA Synthesis Service Market Size Market Share by Type (2021-2032)
Figure 36. World saRNA Synthesis Service Market Size by Batch Scale, (USD Million), 2021 & 2025 & 2032
Figure 37. World saRNA Synthesis Service Market Size Market Share by Batch Scale in 2025
Figure 38. Micro Scale (?1 mg)
Figure 39. Small Scale (>1?100 mg)
Figure 40. Pilot Scale (>100 mg?10 g)
Figure 41. Manufacturing Scale (>10 g)
Figure 42. World saRNA Synthesis Service Market Size Market Share by Batch Scale (2021-2032)
Figure 43. World saRNA Synthesis Service Market Size by Nucleotide Composition, (USD Million), 2021 & 2025 & 2032
Figure 44. World saRNA Synthesis Service Market Size Market Share by Nucleotide Composition in 2025
Figure 45. Unmodified saRNA
Figure 46. Modified saRNA
Figure 47. World saRNA Synthesis Service Market Size Market Share by Nucleotide Composition (2021-2032)
Figure 48. World saRNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World saRNA Synthesis Service Market Size Market Share by Application in 2025
Figure 50. Pharmaceutical and Biotechnology Companies
Figure 51. Academic and Research Institutes
Figure 52. Other
Figure 53. World saRNA Synthesis Service Market Size Market Share by Application (2021-2032)
Figure 54. saRNA Synthesis Service Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. saRNA Synthesis Service Picture
Figure 2. World saRNA Synthesis Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World saRNA Synthesis Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World saRNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World saRNA Synthesis Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company saRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company saRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company saRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company saRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company saRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company saRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company saRNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 13. saRNA Synthesis Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World saRNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India saRNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of saRNA Synthesis Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for saRNA Synthesis Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for saRNA Synthesis Service Markets in 2025
Figure 27. United States VS China: saRNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: saRNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World saRNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World saRNA Synthesis Service Market Size Market Share by Type in 2025
Figure 31. Research Grade
Figure 32. Preclinical Grade
Figure 33. GMP Grade
Figure 34. Other
Figure 35. World saRNA Synthesis Service Market Size Market Share by Type (2021-2032)
Figure 36. World saRNA Synthesis Service Market Size by Batch Scale, (USD Million), 2021 & 2025 & 2032
Figure 37. World saRNA Synthesis Service Market Size Market Share by Batch Scale in 2025
Figure 38. Micro Scale (?1 mg)
Figure 39. Small Scale (>1?100 mg)
Figure 40. Pilot Scale (>100 mg?10 g)
Figure 41. Manufacturing Scale (>10 g)
Figure 42. World saRNA Synthesis Service Market Size Market Share by Batch Scale (2021-2032)
Figure 43. World saRNA Synthesis Service Market Size by Nucleotide Composition, (USD Million), 2021 & 2025 & 2032
Figure 44. World saRNA Synthesis Service Market Size Market Share by Nucleotide Composition in 2025
Figure 45. Unmodified saRNA
Figure 46. Modified saRNA
Figure 47. World saRNA Synthesis Service Market Size Market Share by Nucleotide Composition (2021-2032)
Figure 48. World saRNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World saRNA Synthesis Service Market Size Market Share by Application in 2025
Figure 50. Pharmaceutical and Biotechnology Companies
Figure 51. Academic and Research Institutes
Figure 52. Other
Figure 53. World saRNA Synthesis Service Market Size Market Share by Application (2021-2032)
Figure 54. saRNA Synthesis Service Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
